Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inventors turn to mechanical means for heart innovation; new coatings prolong implant life

This article was originally published in Clinica

Executive Summary

Novel biomaterials were evident amongst December’s list of patent applications, with examples of new composites for orthopaedic use. These include silica zeolite/hydroxyapatite combinations and materials that can promote growth of multiple tissue types. In addition, material science was the key element of a patent application covering a potentially new method for growing cells that could have a major impact on many areas of tissue engineering. In cardiovascular medicine, there were some interesting inventions based on more traditional mechanical methods, as opposed to biological/material methods that seem to have dominated this area of medicine over the past few years. These cardiovascular patent applications include an atherectomy device that takes advantage of centripetal forces to provide a larger cutting diameter in the vessel.

You may also be interested in...



More Than Hot Air: Dyson Wins UK Order For New CoVent Ventilator

UK engineering firm Dyson, best known for its vacuum cleaners, fans and hand driers, plans to make 10,000 specially designed ventilators under a UK government contract.

Ventilator Firms Across Europe Ramp Up Production To Meet ‘Unprecedented’ Demand

Production of ventilators is up by tens of thousands of units across Europe, but the supply chain is likely to come under strain with further expansion. 

ResMed Jumps On Board As Nyxoah Raises €25m For Neurostim Apnea Device

The proceeds from the investment will enable Nyxoah to prepare for the IDE pivotal trial of the Genio system in the US, and accelerate market access and commercialization activities in Europe, Australia and New Zealand.

Topics

UsernamePublicRestriction

Register

MT045286

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel